Safety and Precautions Side Effect Profile Based on available research, 5-Amino-1MQ appears to have a favorable safety profile: Rodent studies have found no significant adverse effects No established human toxicity profile is currently available The most commonly reported effect is potential sleep disturbance An acclimation period may be necessary, with some subjects reporting decreased exercise tolerance with cardiovascular exercise during initial treatment Special Populations and Contraindications Due to limited safety data, the following populations should exercise caution or avoid use until more research is available: Pregnant or breastfeeding individuals Those with chronic health conditions Individuals taking medications that might interact with 5-Amino-1MQ Takeaway 5-Amino-1MQ represents a promising approach for addressing metabolic disorders through NNMT inhibition
Vitamin B12, or cobalamin, is key for many body functions
These products are not drugs, foods, cosmetics, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use
Effect of administration route on the pharmacokinetics of cobalamin in elderly patients: a randomized controlled trial
Clinical trials confirmed that AOD-9604 has no negative impact on glucose metabolism, representing a significant safety advantage for individuals with metabolic concerns
Supplementation of vitamin 12 in amounts up to 1000 mcg can be consumed safely